523 related articles for article (PubMed ID: 18197539)
1. Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.
Mueller TF; Raeder J; Oettl K; Zitta S; Klausmann G; Estelberger W; Luyckx VA; Reibnegger G
Ren Fail; 2008; 30(1):21-9. PubMed ID: 18197539
[TBL] [Abstract][Full Text] [Related]
2. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
[TBL] [Abstract][Full Text] [Related]
3. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
Hoek FJ; Kemperman FA; Krediet RT
Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
[TBL] [Abstract][Full Text] [Related]
6. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
[TBL] [Abstract][Full Text] [Related]
7. Comparison of renal function markers in Kuwaiti patients with sickle cell disease.
Marouf R; Mojiminiyi O; Abdella N; Kortom M; Al Wazzan H
J Clin Pathol; 2006 Apr; 59(4):345-51. PubMed ID: 16567469
[TBL] [Abstract][Full Text] [Related]
8. Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate.
Visvardis G; Griveas I; Zilidou R; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Pavlitou A; Sakellariou G
Transplant Proc; 2004; 36(6):1757-9. PubMed ID: 15350470
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of serum cystatin C for the diagnosis of impaired renal function].
Oyabu C; Hayashi N; Sugiyama D; Umezu M; Mukai M; Kawano S; Kumagai S
Rinsho Byori; 2006 Dec; 54(12):1204-8. PubMed ID: 17265892
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C measurement and its practical use in patients with various renal diseases.
Tian S; Kusano E; Ohara T; Tabei K; Itoh Y; Kawai T; Asano Y
Clin Nephrol; 1997 Aug; 48(2):104-8. PubMed ID: 9285147
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C for estimation of glomerular filtration rate in patients with spinal cord injury.
Jenkins MA; Brown DJ; Ierino FL; Ratnaike SI
Ann Clin Biochem; 2003 Jul; 40(Pt 4):364-8. PubMed ID: 12880536
[TBL] [Abstract][Full Text] [Related]
12. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients.
Villa P; Jiménez M; Soriano MC; Manzanares J; Casasnovas P
Crit Care; 2005 Apr; 9(2):R139-43. PubMed ID: 15774046
[TBL] [Abstract][Full Text] [Related]
13. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
14. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
15. Serum cystatin C as an endogenous marker of renal function in the elderly.
Hojs R; Bevc S; Antolinc B; Gorenjak M; Puklavec L
Int J Clin Pharmacol Res; 2004; 24(2-3):49-54. PubMed ID: 15689051
[TBL] [Abstract][Full Text] [Related]
16. Serum cystatin C as an index of renal function in kidney transplant patients.
Akbas SH; Yavuz A; Tuncer M; Ruhi C; Gurkan A; Cetinkaya R; Demirbas A; Gultekin M; Akaydin M; Ersoy F
Transplant Proc; 2004; 36(1):99-101. PubMed ID: 15013312
[TBL] [Abstract][Full Text] [Related]
17. New predictive equations improve monitoring of kidney function in patients with diabetes.
Beauvieux MC; Le Moigne F; Lasseur C; Raffaitin C; Perlemoine C; Barthe N; Chauveau P; Combe C; Gin H; Rigalleau V
Diabetes Care; 2007 Aug; 30(8):1988-94. PubMed ID: 17536079
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
[TBL] [Abstract][Full Text] [Related]
19. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
Lee BW; Ihm SH; Choi MG; Yoo HJ
Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
[TBL] [Abstract][Full Text] [Related]
20. Variation of serum creatinine, cystatin C, and creatinine clearance tests in persons with normal renal function.
Toffaletti JG; McDonnell EH
Clin Chim Acta; 2008 Sep; 395(1-2):115-9. PubMed ID: 18573244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]